PremiumThe FlyClearwater Analytics upgraded to Overweight from Equal Weight at Morgan Stanley Visa upgraded, MasterCard downgraded: Wall Street’s top analyst calls Clearwater Analytics price target lowered to $30 from $36 at RBC Capital PremiumThe FlyEnfusion downgraded to Market Perform from Outperform at William Blair J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz Enfusion downgraded to Hold from Buy at Stifel PremiumThe FlyEnfusion price target raised to $13 from $11 at Stifel Enfusion, Inc. Reports Strong Q3 2024 Results Enfusion price target raised to $11 from $10 at Stifel 
